Immunotec Inc. announces appointment of President & CEO James A. Northrop
The Board of Directors of Immunotec Inc. announced the appointment of Mr. James A. Northrop as President and Chief Executive Officer, effective November 5, 2007.
A member of the Board of Directors of Immunotec Inc., Mr. Northrop is a seasoned chief executive with a record of success in rapid growth situations, Mr. Northrop has impressive experience in the direct selling, consumer packaged goods, cosmetics, fashion and retail industries. Mr. Northrop has acted as Chairman, Chief Executive Officer and President for a number of companies, including 11 years as the Chairman/CEO of Princess House.
Immunotec's Board of Directors has approved the granting of 700,000 stock options to Mr. Northrop under Immunotec's stock option plan, at a price of $0.66 per share. The closing price of Immunotec shares was $0.66 per share on October 10, 2007.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.